Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study.
about
Statins for age-related macular degenerationStatins for age-related macular degenerationStatins for age-related macular degenerationMacular translocation for neovascular age-related macular degenerationSubmacular surgery for choroidal neovascularisation secondary to age-related macular degenerationMacular translocation for age-related macular degenerationAntiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degenerationStatins for age-related macular degenerationSubmacular surgery for choroidal neovascularisation secondary to age-related macular degenerationAntiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degenerationLaser treatment of drusen to prevent progression to advanced age-related macular degenerationInterferon alfa therapy for age-related macular degenerationAge-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNADietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysisThe prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and AustraliaTherapeutic targets in age-related macular diseaseThe LOC387715 polymorphism and age-related macular degeneration: replication in three case-control samplesA randomised controlled trial investigating the effect of nutritional supplementation on visual function in normal, and age-related macular disease affected eyes: design and methodology [ISRCTN78467674]CFH Y402H confers similar risk of soft drusen and both forms of advanced AMDStatins for age-related macular degenerationAge-Related Macular Degeneration: Advances in Management and DiagnosisToday and future of age-related macular degenerationResistance to antivascular endothelial growth factor treatment in age-related macular degenerationGeographic Atrophy and Choroidal Neovascularization in the Same Eye: A ReviewFive-year incidence and progression of vascular retinopathy in persons without diabetes: the Blue Mountains Eye StudyEmerging therapies for neovascular age-related macular degeneration: state of the artNine loci for ocular axial length identified through genome-wide association studies, including shared loci with refractive errorTreatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapyCoaxial Electrospray of Ranibizumab-Loaded Microparticles for Sustained Release of Anti-VEGF TherapiesA mitochondria-localized glutamic acid-rich protein (MGARP/OSAP) is highly expressed in retina that exhibits a large area of intrinsic disorderInsights into the genetic architecture of early stage age-related macular degeneration: a genome-wide association study meta-analysis.Association of Age Related Macular Degeneration and Age Related Hearing Impairment.Scotopic microperimetry in the early diagnosis of age-related macular degeneration: preliminary study.Cone structure imaged with adaptive optics scanning laser ophthalmoscopy in eyes with nonneovascular age-related macular degeneration.Extracts from "clinical evidence": age related macular degenerationCurrent concepts and recent advances in the management of age-related macular degeneration.Issues in assessing the validity of nutrient data obtained from a food-frequency questionnaire: folate and vitamin B12 examples.New treatments in age-related macular degeneration.Estimation of Flavonoid Intake in Older Australians: Secondary Data Analysis of the Blue Mountains Eye Study.Scanning laser entoptic perimetry for the detection of age-related macular degeneration.
P2860
Q24188161-98F70D92-409F-4E97-B7FB-B50D58AB5B00Q24201178-F5DEA78D-A1F8-4A6B-A041-883D782E5512Q24240102-3E5C841A-6572-4C67-A187-86119967DE44Q24241142-4EAA7FB4-D89E-4248-BBA1-F7A992918E50Q24241790-A4DF6280-4B00-4C31-8415-54A12790104CQ24243002-9A31A3FD-C8EE-49C1-B6C4-F5D8110D5ABAQ24243234-4CF59011-000D-4917-A90E-5ACA91AF1DA3Q24243472-CC016F87-E087-4A14-90EB-26DF0B9222F5Q24243677-C5462999-044C-43E6-9138-094791066A97Q24245483-B99ADC34-35FA-479A-B227-1EDE1358A88EQ24245721-3B546A22-C971-47C8-A862-1BE2A77A9627Q24246549-7EF722F9-2168-498D-A3D0-65DE9DE16975Q24317658-5DB58C5E-DDB4-404A-AA43-A8EB8DF99C2DQ24569500-4416197D-608E-46DE-A53D-AA85802C9CABQ24601205-16E87EF9-4664-4DDF-8EEE-45568F01B8AAQ24623107-1F54CE70-3982-4F3A-8A0A-C8A98C66D94FQ24678569-DF7F6A4D-579B-4463-93A8-2A6C10DE116DQ24806062-E3351593-3F3A-4507-A747-29A0574E27A9Q24811235-83B0D35A-11AD-490D-9AA5-F4CB7940F95AQ26470515-0F486F16-4CF8-45E2-9067-0F289735F883Q26799617-5E144AE1-7EFE-4E56-B609-5C62EFED2CA6Q26865643-E5128D4C-4BB7-47BD-9844-E27CA248DB69Q27015781-82770677-9C34-4EC5-9741-5C5B6909483FQ28074640-640C0AD3-F249-4CE4-9E31-C37F281E345BQ28191911-7C55C2F0-3F17-4A3A-92AA-A25F9D55608FQ28253918-0B2EC063-5BB2-42EF-96BF-331CF0D25350Q28300637-902E821B-D76C-4B69-AEC5-DA33E3A8E117Q28361141-85BDA7AC-CEED-4047-AE0B-262D5E5C5DC4Q28547260-EF092475-359E-4C38-8199-D0BEDCEEC432Q28588051-2D80C5C5-D59E-4A17-9895-82D673FD0610Q29417048-820E0BD8-41F5-421C-9829-0731B8EFEE49Q30383601-712D42E3-EC4E-4F65-86E3-269180BA85D7Q30422343-5A2F40A0-7EE9-4CB6-83B0-2EB76DFCB1FAQ30557413-EBABE95D-4EFE-4713-B60C-6C86511CA029Q30657044-46C8FF73-652C-4531-AFAB-ACC5724C36D2Q30759391-23FE0A1D-01E9-4A8D-85CE-3ADEA45FA3DEQ30959375-C3C21CF4-FC0B-4744-BB2B-883593C7094FQ31004243-544D1163-1478-4805-8BD0-C495ABC1A590Q31023922-941A91B4-BEE1-48F0-9F48-BFE9BD38C91DQ31126206-4E7AC458-E2AA-4069-8157-F772EB61488F
P2860
Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study.
@en
Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study.
@nl
type
label
Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study.
@en
Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study.
@nl
prefLabel
Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study.
@en
Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study.
@nl
P2093
P1433
P1476
Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study.
@en
P2093
P304
P356
10.1016/S0161-6420(95)30846-9
P577
1995-10-01T00:00:00Z